Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
出版年份 2022 全文链接
标题
Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
作者
关键词
-
出版物
International Journal of Environmental Research and Public Health
Volume 19, Issue 23, Pages 15981
出版商
MDPI AG
发表日期
2022-11-30
DOI
10.3390/ijerph192315981
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sclerostin Protects Against Vascular Calcification Development in Mice
- (2022) Annelies De Maré et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of Sclerostin in Cardiovascular Disease
- (2022) Jonathan Golledge et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Adipokines Level and Cognitive Function—Disturbance in Homeostasis in Older People with Poorly Managed Hypertension: A Pilot Study
- (2022) Agnieszka Kujawska et al. International Journal of Environmental Research and Public Health
- Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders
- (2021) Natalia Carrillo-López et al. CALCIFIED TISSUE INTERNATIONAL
- Overview of the socio-economic consequences of heart failure
- (2021) Franz P. Hessel Cardiovascular Diagnosis and Therapy
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
- (2020) Gerhard Klingenschmid et al. Journal of the American Heart Association
- Sclerostin and Vascular Pathophysiology
- (2020) Antonino Catalano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
- (2020) Jonas Bovijn et al. Science Translational Medicine
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. ATHEROSCLEROSIS
- Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
- (2019) Fang Lv et al. BONE
- Sclerostin within the chronic kidney disease spectrum
- (2019) Antoine Bouquegneau et al. CLINICA CHIMICA ACTA
- Improved carotid intima-media thickness-induced high-intensity interval training associated with decreased serum levels of Dkk-1 and sclerostin in type 2 diabetes
- (2019) Alireza Ghardashi-Afousi et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Is Sclerostin Level Associated with Cardiovascular Diseases in Hemodialysis Patients?
- (2018) Gokce Kundakci Gelir et al. BLOOD PURIFICATION
- Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
- (2018) Hanne Skou Jørgensen et al. CLINICAL NEPHROLOGY
- Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients
- (2018) Li Gong et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Circulating levels of sclerostin are associated with cardiovascular mortality
- (2018) Cristina Novo-Rodríguez et al. PLoS One
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
- (2018) Andrea C. Tricco et al. ANNALS OF INTERNAL MEDICINE
- Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)
- (2018) Anna Wędrychowicz et al. BONE
- Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke
- (2018) K. Mathold et al. PLoS One
- Response of Sclerostin and Bone Turnover Markers to High Intensity Interval Exercise in Young Women: Does Impact Matter?
- (2018) R. Kouvelioti et al. Biomed Research International
- Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D
- (2017) Xue-Rong Wang et al. NEPHROLOGY
- Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
- (2017) Geert J. Behets et al. PLoS One
- High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke
- (2016) Xin-Wei He et al. ATHEROSCLEROSIS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis
- (2016) Mehmet Kanbay et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2016) Valery L Feigin et al. LANCET NEUROLOGY
- Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women
- (2016) Sumika Matsui et al. MATURITAS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) et al. European Journal of Preventive Cardiology
- Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism
- (2015) Giuseppe Daniele et al. DIABETES CARE
- Differential sclerostin and parathyroid hormone response to exercise in boys and men
- (2015) B. Falk et al. OSTEOPOROSIS INTERNATIONAL
- Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
- (2014) Mehmet Kanbay et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
- (2014) C. Drechsler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Obesity and US Mortality Risk Over the Adult Life Course
- (2013) R. K. Masters et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. CIRCULATION
- The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
- (2013) S. Pelletier et al. Clinical Journal of the American Society of Nephrology
- Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
- (2013) S. Morales-Santana et al. DIABETES CARE
- Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
- (2013) Vincent M Brandenburg et al. BMC Nephrology
- Mechanical stimuli and bone health
- (2012) Angela M. Cheung et al. CURRENT OPINION IN RHEUMATOLOGY
- Forecasting the Future of Cardiovascular Disease in the United States
- (2011) Paul A. Heidenreich et al. CIRCULATION
- Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
- (2011) Antonia García-Martín et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
- (2010) Ulrike I Mödder et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started